Prospective study of immunomodulation with GM-CSF, IL-2, and rituximab following autologous stem cell transplant (SCT) in patients with relapsed lymphomas.

被引：0
|
作者：
Smith, SM
Grinblatt, DL
Gajewski, T
Harlin, H
Welborne, K
Conner, K
Larson, RA
Rich, E
Odenike, O
Zimmerman, T
van Besien, K
机构：
[1] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[2] Northwestern Univ, Evanston, IL USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.918.918
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
918
引用
收藏
页码：263A / 263A
页数：1
相关论文
共 50 条
  • [1] Randomized study of GM-CSF post peripheral blood stem cell (PBSC) transplant with PBSC collected with GM-CSF in lymphomas.
    Colombat, P
    Gardembas, M
    Delwauil, V
    Milpied, N
    Abgrall, JF
    Chassagne, I
    Tabah, E
    Delain, M
    BLOOD, 1996, 88 (10) : 1190 - 1190
  • [2] Pilot study of post-transplant immunomodulation with GM-CSF and IL-2 in patients with high-risk relapsed/refractory B cell non-Hodgkins lymphoma (NHL).
    Smith, SM
    Liebowitz, DN
    Zimmerman, TM
    Williams, SF
    Grinblatt, DL
    BLOOD, 2000, 96 (11) : 349B - 349B
  • [3] Dendritic cell reconstitution following autologous stem cell transplant with GM-CSF support for multiple myeloma
    Schlueter, Annette J.
    Glasgow, Judith K.
    Wilke, Werner
    Marietta, Jacquie R.
    Hohl, Raymond J.
    Carter, Thomas H.
    Gingrich, Roger D.
    Magalhaes-Silverman, Margarida D.
    BLOOD, 2007, 110 (11) : 289A - 290A
  • [4] Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas
    Poire, Xavier
    Kline, Justin
    Grinblatt, David
    Zimmerman, Todd
    Conner, Kathy
    Muhs, Carolyn
    Gajewski, Thomas
    Van Besien, Koen
    Smith, Sonali M.
    LEUKEMIA & LYMPHOMA, 2010, 51 (07) : 1241 - 1250
  • [5] RANDOMIZED STUDY OF GM-CSF POST PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANT WITH PBSC COLLECTED WITH GM-CSF IN LYMPHOMAS
    COLOMBAT, P
    GARDEMBAS, M
    DELWAIL, V
    MILPIED, N
    ABGRALL, JF
    CHASSAGNE, I
    TABAH, E
    DELAIN, M
    BLOOD, 1994, 84 (10) : A705 - A705
  • [6] Interleukin 2 (IL-2) and granulocyte-macrophage colony stimulating factor (sargramostin) (GM-CSF) following autologous peripheral blood stem cell transplant (ASCT) for breast cancer
    Holmberg, LA
    Bensinger, W
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 98 - 99
  • [7] GM-CSF vs. G-CSF: Engraftment characteristics following autologous peripheral blood stem cell transplant.
    Zumberg, MS
    Nejame, CS
    Leather, HL
    Moreb, JS
    Reddy, VS
    Khan, SA
    Finiewicz, KJ
    Eagle, DA
    Meyer, C
    Wingard, JR
    BLOOD, 2000, 96 (11) : 297A - 297A
  • [8] G-CSF versus GM-CSF after autologous peripheral blood stem cell transplant: A resource utilization study.
    Jansen, J
    Thompson, EM
    Hanks, S
    Greenspan, A
    Dugan, MJ
    Thompson, JM
    Akard, LP
    BLOOD, 1998, 92 (10) : 130A - 130A
  • [9] GM-CSF & IL-2 ± autologous whole cell vaccine as adjuvant therapy in cutaneous melanoma: A phase II clinical trial
    Beam, S. L.
    Elias, E. G.
    Zapas, J. L.
    McCarron, E. C.
    Hasskamp, J. H.
    Culpepper, W. J., II
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Concurrent and sequential administration of interleukin-2 (IL-2) and granulocyte-macrophage colony stimulating factor (GM-CSF) for immune activation following high dose chemotherapy (HDC) and autologous stem cell transplant (ASCT).
    Bachier, C
    Teale, J
    Lanzkron, S
    Hougham, M
    Nanez, A
    Huerta, J
    Childs, C
    LeMaistre, CF
    BLOOD, 1998, 92 (10) : 360B - 360B
12345